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Abstract 
 
The purpose of this critical commentary is to highlight the inconsistencies evident within the discourse of Performance Enhancing Drug (PED) 
use and Anti-Doping violations. Of most note, the issue related to proper rehabilitation and subsequent reintegration of athletes who have failed 
drugs tests is reliant on a notion that when athletes return to competition, fairness will prevail. We know that PEDS, in particular steroids and 
exogenous hormone treatment, confer an advantage even without concurrent training (see Bhasin et.al. 1996). That their effectiveness is not in 
doubt is consistent with current policy. However, the question of just how advantageous it is for athletes to use them, even just the once, and 
whether there are any permanent advantages to doing so, is not particularly evident in contemporary discourse. This paper takes the position, 
using emerging scientific evidence as well as the recollections of UK strength sports administrators, that any consideration of ‘clean’ sport needs 
to resolve policy with the evidence that permanent advantages accrued from PED use can only be combatted by promoting a ‘natural for life’ 
standard. 
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Currently, the World Anti-Doping Agency’s (WADA) Anti-Doping Rule Violations (ADRVs) allow a 
sliding scale of transgressions to take place with no lifetime bans given in the first instance of a failed test. 
However, this perpetuates a system that ultimately does not distinguish between those who have never used 
Performance Enhancing Drugs (PEDs) and those who have. There is, however, and as we will outline, a very 
real distinction between these two categories. This is particularly so when the nature of the PEDs moves 
away from the more temporary acting examples (for instance, stimulants and diuretics) to exogenous 
hormones administered to increase performance (such as anabolic steroids and growth hormones). Discourse 
regarding this issue remains typically undeveloped, at best so marginal, as to have not entered any real debate 
concerning the morality of drug use within sport. What discourse there is inevitably relies far more on the 
principles of how to deal with those who have failed a test once or even several tests (for instance Justin 
Gatlin in the Olympics, and Jon Jones in the Ultimate Fighting Championship [UFC]), and how they can be 
both rehabilitated and reintroduced into mainstream sport. We therefore argue that any consideration of how 
to test, what to test for, how to penalise failed tests, and whether sport should allow drug use (e.g. see 
Savalescu et al, 2004) needs to be reframed. This is especially relevant given that the prevailing argument 
related to the use of PEDs within sport and subsequent reintegration lacks a considered engagement with 
key scientific research. 
 
A seemingly perpetual succession of drug scandals within sport over the last 40 years illustrates 
that individual athletes, training camps, coaches, and even state sponsored federations (perhaps most notably 
the former East Germany in the 1960s and 70s) encouraged and facilitated a culture of systematic PED use. 
Yet despite efforts, every decade since the 1980s, with Ben Johnson’s positive test at the 1988 Seoul 
Olympics of particular note, has seen major drug scandals in sport. Some of the more notable cases were the 
Irish swimmer Michelle Collins in the 1990s, the Bay Area Laboratory Co-Operative (BALCO) scandal (that 
ultimately led to the fall of Marion Jones and Tom Montgomery) in the early 2000s, Lance Armstrong’s 
eventual lifetime ban from the Union Cycliste Internationale (UCI) in 2012 (that initiated soul searching 
within cycling from the 2000s to the present), and the continuing issues of state sponsored programmes (such 
as Russia) within the 2010s.  
 
More recently, the major sports leagues in the USA continue to be beset by repeated instances of 
PED use that seem to appear to suggest a permissive culture. Alongside this, the continued monitoring of 
some state sport systems, such as Russia, is still beset with problems. Now there are increased calls to 
examine what seems to be the incredibly high prevalence of athletes with medical conditions that require 
what some, perhaps cynically, but perhaps entirely pragmatically, state might be fortuitously timed episodes 
of medicinal (with acknowledged performance enhancing qualities) intervention that fall under the banner 
of Therapeutic Use Exemption (TUE). Examples include episodes initially exposed by the cyber-espionage 
group the Russian Fancy Bears who released documents related to multiple British sport stars and include 
the incidents regarding the British cyclists Bradley Wiggins and Chris Froome. Added to this there is now 
what seems to be a partial redistribution of medals and places from the 2008 and 2012 Olympic Games 
thanks to developments in testing procedures and the retesting of older samples. It is no surprise then that 
public opinion of professional and elite sport being rife with PEDs is palpable. 
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In truth, some believe that it is difficult for any part of life to be completely drug free at this point 
in contemporary postindustrial society, with an argument that drugs (whether legal, recreational, illegal, or 
PEDs) are completely integrated and normalised into everyday life and that to separate athletes from this 
reality would be impossible. Indeed, the notion of drug free sport is further questioned by many who believe 
that there are a range of factors that cloud issues of morality, whilst at the same time promoting how regulated 
drug use could reduce what we already know regarding the dangers of drug use in sport (Coakley and Pike, 
2009). The founding premise adopted here then, is that a system which monitors athlete risk and mitigates 
potential damage to health through medical intervention is one that is more realistic and more attuned to the 
realities of modern life.  
 
This manner of concession then, one explicitly or implicitly stating that the battle against PEDS 
is futile, suggests that given contemporary prevalence and sophistication, testing is now redundant 
(Savalescu et al, 2004). This outlook appears to shift the use of PEDs in sport to a more permissive system 
of explicitly monitoring athlete health against known risk factors rather than the current preventative system 
(Schneider & Butcher, 2000). The argument for allowing PED use also stretches into one that asks questions 
of how excellence in non-sport fields is facilitated. Savalescu et al. (2004), for instance, highlight the fact 
that other performance type ‘art’ allows or encourages recreational drugs to enhance creativity; that the 
‘spirit’ of sport would be enhanced by allowing genetic manipulation; that allowing drugs would permit an 
even playing field; and that permitted drug use would be safer overall. 
 
In response to this line of argument Devine (2010) reasoned against permitting PEDs because it 
would unsettle the ‘balance of excellences’ in sport (e.g. power vs skill) with a consequential reduction in 
audience enjoyment. Devine (2010) also raises the moral objection against PEDs in that sport is defined as 
an activity in which participants agree to adhere to the rules. Here, Devine (2010) draws upon the classic 
work of Suits (1978), who stated that the very essence of games and sports was that the participants would 
adhere to the rules. This definition helps establish what can be considered a clear distinction of what sport 
‘is’, i.e. an activity that fundamentally places the idea of mutually agreed guidelines and typically inefficient 
means to complete goals, as the centrepiece. Within this wider debate Kayser and Smith (2008) argue for 
greater leniency, citing the rising cost-benefit of drug testing, while Pope et al. (2014) urge caution against 
this approach given current ignorance surrounding long-term adverse consequences of PED use, including 
the withdrawal symptoms associated with suppressed hypothalamic-pituitary-testicular (HPT) function and 
mental health conditions.  
 
Whilst some argue that the majority of top class athletes use PEDs (thus in their eyes obviating 
the need to monitor lower level sport) and that, as mentioned previously, drug use is commonplace in modern 
society, that all drugs carry risks, and that these risks should prove to be the burden of individuals, testing 
for PEDs within sport does still take place. This appetite for drug testing remains with WADA, and other 
organisations, to police the use of PEDs in sports. We argue that it is essential to continue this policing yet 
also call for a wider discussion regarding the use of PEDS because any argument either for leniency or for 
specific periods of ban does not consider the long-lasting effects of PED use. These effects are, in no 
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uncertain terms, advantages conferred to even one-time users of PEDS such that athletes continue to benefit 
post use. As emerging evidence shows, these advantages may be on a permanent basis, rendering any PEDs 
transgression ultimately worthwhile if natural barriers to excellence have been broken. This therefore either 
removes the option of winning for clean athletes, perhaps even at amateur level, or forces them to take PEDs 
in order to maintain any sense of parity with those who do or, and central to our argument, ever have.  
 
There are two fundamental elements underpinning our position. The first argument is relatively 
simple, in that any idea of creating a level playing field by allowing PEDs neglects to take into account what 
are very simple medicinal understandings of reactions to all drugs - with, for instance, common and 
uncommon reactions (again, simple medicinal terminology) and side effects to drugs by definition 
acknowledging that individuals react differently to the same drugs and/or dosages. Extending this 
understanding to the context of PEDs, this means that there can be a wide variation in the way that individuals 
may experience both performance enhancing and negative side-effects. Put simply, someone might well just 
have a fantastic genetic predisposition to respond very positively to certain types of PEDs, which, as we 
currently understand it, is not considered a talent (admittedly at the moment). Under a more permissive 
system, then, sporting success may partially rely on a genetic predisposition to optimal PED response. 
 
The second argument is perhaps more complicated, but also represents the main thrust of this 
article. A reframing of the argument for allowing drugs and indeed even for allowing athletes that have failed 
drugs tests and served bans before coming back, is necessary. This is due to emerging evidence suggesting 
that using certain PEDs (e.g. exogenous anabolic steroids) results in permanent morphological changes, 
which subsequently confer lifetime advantages to any PED user in comparison with a ‘clean’ athlete . If this 
is so, the debate needs to be opened up far more explicitly and critically at this point and to encompass the 
conflicting tension between allowing for rehabilitation of offenders and explicitly recognising that doing so 
facilitates a continuing disparity in terms of fairness.  
 
We acknowledge that the evidence in this respect is far from complete. Some is suppositional, 
extrapolating upon the work undertaken by Egner et al. (2013) on mammals. In their study, Egner et al. 
(2013) subjected female mice to episodes of either a) an experimental group experiencing testosterone 
exposure (through a pellet inserted in the skin of their necks) for 14 days, or b) a control group experiencing 
placebo pellets with no testosterone. They found that the number of myonuclei in the group subjected to 
testosterone therapy increased by 66%, with an increase also in fibre cross-sectional fibre area (CSA) of 
77%.  Importantly, while fibre size for this group decreased to baseline levels after three weeks, the increase 
in myonuclei was observed at a three-month follow-up. On reintroduction of overload-exercise, fibre CSA 
areas grew by 31% while controls grew only 6%. This increase in myonuclei persisted long after the 
administration of the drug, strongly indicating permanent change. Clearly, any extrapolation to humans must 
accept that mammalian function and response to cellular memory follow similar pathways (Allen et al., 1995; 
Gunderson, 2016). In the context of human physical performance, therefore, the advantages conferred by 
additional myonuclei in sport would be enhanced muscle contractile activity and strength, and increased 
capacity for hypertrophy. These are significant components that underpin sports performance, increasing 
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concerns that PED use in humans will demonstrate results, potentially including permanently increased 
muscle myonuclei.  
 
Indeed, there already is some evidence that suggests this is the case. Using a small sample of 
competitive powerlifters, Eriksson (2006) studied current PEDs users (n=9), those that had never used PEDs 
(n=10), and those that had previously used PEDs (n=7). Biopsies from participants trapezius and vastus 
lateralis muscles indicated increased fibre areas and myonuclei, as well as increased central nuclei, within 
both those who were currently using and those who had previously used PEDs, concluding that “some of the 
morphological changes induced by testosterone and anabolic steroids are very long lasting, perhaps life-
long” (p. 42).  
 
Moreover, Crisp’s research, (2016a; 2016b), tracing the history of strength sports in the United 
Kingdom, revealed what can be considered a rife and unchecked PEDs culture at the time. Exploring the 
recollections and stories of some of the key administrators of strength sports in the UK reveals their attempt 
to create ‘lifelong’ natural strength movements to counter this PEDs culture. This approach to creating 
lifetime drug-free lifting federations was underpinned by a variety of examples from the participants (the 
key administrators) in the study. For example, all of them recollected seeing many people improve from 
regional to near international status in very short periods of time and improving approximately 20% after 
having had static performances for a decade or more. They also reported beliefs that any accrued 
improvements were also, once the PEDs were discontinued, still above the previously ‘naturally’ held limit 
that the users had reached. These recollections then support the findings of the scientific community through 
observations of PED users and the effects, when ‘on’ and ‘off’ drugs over a period of 30+ years, strongly 
endorsing the message that there are permanent effects of drug use beyond a single episode of consumption. 
 
While the issues of long-term advantages of PED use within humans remains inadequately 
studied, Egner et al. (2013) and Gunderson (2016) have already called for a reconsideration  of continued 
athlete eligibility in the context of failed tests. As it stands then, enough evidence exists to at least call into 
question any argument related to the use of drugs within sport that allows subsequent rehabilitation of 
offenders. There is also sufficient evidence to suggest that drug cheats are prospering from the permanent 
advantages that even a single episode of drug use confers. Furthermore, this raises the spectre of tactical 
drug use early in athletes’ careers whereby the prospect of being caught is insufficiently punitive. Or, having 
been caught, the prospect that long term benefits will continue into their later careers. 
 
Consequently, we argue that if we are to develop the debate on the policing of PED use, then an 
informed and evidence-based understanding of the exact consequences PEDs imbue, regarding permanently 
breaking natural barriers to excellence, must be established. This is especially so when considering an ethical 
and moral viewpoint, as at present this information is not being taken into account in these debates and 
judgements. In short, some may need to acknowledge that any move away from performance, doping, and 
elitism, to values of fairness and equity, requires a clean for life movement with zero tolerance of PED use. 
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